Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2025Frontiers in ImmunologyOpen Access

Editorial: Cellular and molecular regulators in non-neoplastic immune-mediated diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

NENoha Mousaad ElemamITIman M. TalaatOMOmar El Meligy

Discussion

Loading...

Member takes

Overview

Editorial highlights the role of cytokines and immune cell subsets in autoimmune disorders, suggesting new therapeutic strategies.

Key Points

  • Chronic inflammation and tissue damage are driven by cellular and molecular regulators in immune-mediated diseases.
  • Novel therapies targeting immune cell subsets and cytokines show potential for enhancing diagnosis and patient outcomes.
  • Dysregulated immune mechanisms contribute directly to chronic wounds, exemplifying the need for targeted regenerative therapies.
  • Advances in understanding transcription factors and immune mediators present new avenues for innovative treatments of autoimmune diseases.

Cite This Study

Elemam et al. (2025) studied this question.

synapsesocial.com/papers/68d43285713b0b5dfea71bcehttps://doi.org/10.3389/fimmu.2025.1694308
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Editorial: Immune tolerance dual role: advancements in cancer and autoimmune diseases2025
  2. 2Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?2025 · 47 citations
  3. 3Cytokines, Kinases, and Beyond: Advancing Next-generation Immunomodulatory Strategies and Precision Small-molecule Therapies in Autoimmune Disease2025
  4. 4Editorial: Repurposing cancer immunotherapies for use in autoimmunity and transplantation2025
  5. 5Comprehensive Profiling of Cytokines and Growth Factors: Pathogenic Roles and Clinical Applications in Autoimmune Diseases2025 · 18 citations